does semaglutide affect pancreas GLP-1 Side Effects and Semaglutide: Why Smart Biomarker Monitoring Matters Risk of pancreatic cancer associated

Curr Opin Pharmacol (2016) 31:449

10.1016/j.tcm.2021.12.008

Single and dual agonists The fundamental difference between these two molecules is that semaglutide is a GLP-1 agonist, i.e., it has a strong structural similarity (95%) with this hormone and specifically activates its receptor, while tirzepatide is a dual agonist, i.e., it has a hybrid structure that allows it to activate both GLP-1 and GIP receptors (Figure 2)

This condition can lead to serious health problems, including seizures, fainting, or stroke-like symptoms

When it comes to managing your weight, understanding your options is the first step towards a healthier you